Abstract:PROBLEM: To examine whether the occurrence of activated protein C resistance (APCR) and factor V Leiden mutation differs in women with first‐ compared to women with second‐trimester unexplained recurrent pregnancy loss. METHOD OF STUDY: Seventy eight consecutive women with two or more unexplained post‐embryonic recurrent pregnancy losses and 139 fertile women with at least one successful pregnancy and no abortions were prospectively investigated for APCR and the factor V Leiden mutation. No women were pregnant at the time of investigation. APCR was defined as APC–sensitivity ratio (APC–SR) of ≤2.0. All patients with an APC–SR ≤2.4 were investigated for the factor V Leiden mutation. Women in this study were divided into three groups. Group A included only women with a history of recurrent first‐trimester embryonic loss (37 women) and Group B included women with second‐trimester abortions with or without additional first‐trimester abortions (41 women). Group C included the controls (139 women). RESULTS: APCR and factor V Leiden mutations were significantly more prevalent in all recurrent pregnancy loss patients in this study as compared to controls, 38% (30/78) and 19% (15/78) in contrast to 8% (11/139) and 6% (8/139), respectively. All three groups in the study were comparable regarding age, parity, and number of living children, whereas Groups A and B were also comparable regarding gravidity. Mean APC–SRs were significantly higher in Group C as compared to Groups A and B. The incidence of APCR was significantly higher in Groups A and B, as compared to controls, 27 and 49% in contrast to 8%, respectively. Moreover, the incidence of the factor V Leiden mutation was significantly higher in Groups A and B as compared to Group C, 16 and 22% as distinct from 6%, respectively. The incidence of APCR was higher in Group B as compared to Group A, 49% in contrast to 27%, with borderline significance; however, the factor V Leiden mutation did not significantly differ between the two groups. CONCLUSIONS: APCR and factor V Leiden are associated with unexplained recurrent pregnancy loss. The occurrence of APCR and factor V Leiden seems to be linked to post‐embryonic first‐trimester as well as second‐trimester recurrent pregnancy loss. The significance of acquired, non‐heritable APCR in recurrent fetal loss patients, especially in the second‐trimester aborters, is still to be determined.

MAGNETIC NANOMATERIALS FOR MAGNETIC BIOANALYSIS

Recent Advances in Biological Detection with Magnetic Nanoparticles As A Useful Tool

Magnetic Nanomaterial and Its Applications in Biomedicine

Improved management in the diagnosis of gonorrhoea in women.

Magnetic Nanoparticles in Nanomedicine

[The Progress of Magnetic Nanomaterials in Application of Biomedicine].

Activated Protein C Resistance and Factor V Leiden Mutation can be Associated with First‐ as well as Second‐Trimester Recurrent Pregnancy Loss 1

The Recent Applications of Magnetic Nanoparticles in Biomedical Fields

Duplex and color-flow imaging of the lower extremity arterial circulation.

[Current approaches to the prevention and treatment of osteoporosis: the role of calcium and vitamin D].

Magnetic Nanoparticles: A Review on Synthesis, Characterization, Functionalization, and Biomedical Applications

Application of magnetic nanoparticles in nucleic acid detection

Current Investigations into Magnetic Nanoparticles for Biomedical Applications

Magnetic Microsphere and Its Use in Biochemical Separation and Analysis

Magnetic Particles for Multidimensional In-vitro Bioanalysis

In Vitro Biological Effects of Magnetic Nanoparticles

Magnetic Nanomaterials for Sample Preparation of Disease-related Biomarkers

Nanomagnetism: Principles, Nanostructures, and Biomedical Applications

A Review of Magnetic Nanoparticle-Based Surface-Enhanced Raman Scattering Substrates for Bioanalysis: Morphology, Function and Detection Application

Research and Development of Medical Magnetic Nanomaterials

Magnetic needles and superparamagnetic cells